Profusa, Inc.

Name: Profusa, Inc. standardized financial statements, quarterly
Creator: Listed

PFSANasdaqCIK 1859807HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2024

Operating income−$2.5m, Q2 FY2026

Net income−$8.8m, Q2 FY2026

Profusa, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	not reported	not reported	not reported	not reported	0.1	0.0	not reported	not reported	not reported	not reported	not reported	not reported
Research and development	$m	not reported	not reported	not reported	not reported	0.4	0.3	0.4	0.4	0.7	1.3	1.1	0.8
Operating income	$m	(0.3)	(0.5)	(0.5)	(0.3)	(1.1)	(1.1)	(1.4)	(1.0)	(21.7)	(3.6)	(4.0)	(2.5)
Interest expense	$m	not reported	not reported	not reported	not reported	1.1	1.3	1.1	1.2	0.2	0.0	0.0	0.0
Income tax	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	not reported	not reported	not reported	not reported
Net income	$m	(0.4)	0.2	(2.1)	(2.4)	(2.5)	(2.3)	(2.7)	(2.3)	(22.2)	(8.6)	(3.5)	(8.8)
Diluted EPS	$ per share	(0.06)	not reported	(0.14)	(0.07)	(1.29)	not reported	(105.09)	(9100.78)	(0.70)	not reported	(2.05)	(151.80)
Basic EPS	$ per share	(0.06)	not reported	(0.14)	(0.07)	(1.29)	not reported	(105.09)	(9100.78)	(0.70)	not reported	(2.05)	(151.80)

Balance sheet

Cash and equivalents$12.2m, Q2 FY2026

Long-term debt$713.0k, Q3 FY2023

Shareholders' equity−$27.1m, Q2 FY2026

Profusa, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.0	0.0	0.0	0.0	0.0	0.2	not reported	not reported	3.0	1.8	0.4	12.2
Current assets	$m	0.2	1.6	0.1	0.1	0.7	0.3	0.1	0.7	4.2	3.8	0.7	0.8
Total assets	$m	10.8	10.9	8.5	8.6	8.8	3.1	2.0	2.0	4.3	3.8	0.9	1.0
Current liabilities	$m	3.0	4.9	4.0	4.2	5.2	57.1	13.3	16.2	23.5	22.3	29.0	28.2
Total liabilities	$m	3.7	5.1	4.6	5.1	5.8	57.1	14.3	23.1	38.2	30.4	29.1	28.2
Long-term debt	$m	0.7	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$m	not reported	0.2	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	(3.5)	(110)	(112)	(114)	(117)	(119)	(122)	(124)	(34.0)	(26.7)	(28.2)	(27.1)

Cash flow

Operating cash flow−$2.6m, Q2 FY2026

Capital expenditure$73.0k, Q2 FY2026

Share repurchases$0, Q2 FY2025

Profusa, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(480)	(345)	(281)	(395)	(1,152)	(238)	(537)	(589)	(9,993)	(5,129)	(2,576)	(2,632)
Capital expenditure	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	5.0	73.0
Share repurchases	$k	0.0	0.0	2,653	0.0	0.0	595	6,511	0.0	not reported	not reported	not reported	not reported

Diluted shares (weighted)57,676, Q2 FY2026

Profusa, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	5.2	5.2	5.2	5.2	5.2	5.2	1.9	0.0	0.0	31.7	1.7	0.1

Shares outstanding: 605,647 at Aug 18, 2026, from the cover of the 10-Q filed Aug 19, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.